|
|||||
|
|
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody‐dependent cell‐mediated cytotoxicity and complement‐dependent cytotoxicity |
|
| Abstract: | |
| Keywords: | CD20 antibody therapy ADCC myeloid effector cells IgA antibody |